Terms: = Lymphoma AND ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR-1, MXR1, UAQTL1 AND Prognosis
10 results:
1. Multiplex Single-Cell Analysis of Cancer Cells Enables Unbiased Uncovering Subsets Associated with Cancer Relapse: Heterogeneity of Multidrug Resistance in Precursor B-ALL.
Zhou Y; Wai-Choi Tse E; Leung R; Cheung E; Li H; Sun H
ChemMedChem; 2022 Feb; 17(3):e202100638. PubMed ID: 34783169
[TBL] [Abstract] [Full Text] [Related]
2. Expression of the cancer stem cell markers abcg2 and OCT-4 in right-sided colon cancer predicts recurrence and poor outcomes.
Hu J; Li J; Yue X; Wang J; Liu J; Sun L; Kong D
Oncotarget; 2017 Apr; 8(17):28463-28470. PubMed ID: 28212529
[TBL] [Abstract] [Full Text] [Related]
3. [Interleukin-23 strengthens the anti-apoptotic and drug resistance of human tongue squamous cell carcinoma through the Wingless-related integration site/β-catenin pathway].
Yan Q; Su Y; Zhou Y; Zhu H; Yang X; Xu J
Hua Xi Kou Qiang Yi Xue Za Zhi; 2015 Jun; 33(3):249-54. PubMed ID: 26281251
[TBL] [Abstract] [Full Text] [Related]
4. The clinical significance of FRAT1 and abcg2 expression in pancreatic ductal adenocarcinoma.
Yuan Y; Yang Z; Miao X; Li D; Liu Z; Zou Q
Tumour Biol; 2015 Dec; 36(12):9961-8. PubMed ID: 26178481
[TBL] [Abstract] [Full Text] [Related]
5. Identification of a novel, tissue-specific abcg2 promoter expressed in pediatric acute megakaryoblastic leukemia.
Campbell PK; Zong Y; Yang S; Zhou S; Rubnitz JE; Sorrentino BP
Leuk Res; 2011 Oct; 35(10):1321-9. PubMed ID: 21640380
[TBL] [Abstract] [Full Text] [Related]
6. Impact of breast cancer resistance protein on cancer treatment outcomes.
Ross DD; Nakanishi T
Methods Mol Biol; 2010; 596():251-90. PubMed ID: 19949928
[TBL] [Abstract] [Full Text] [Related]
7. [Gene expression of breast cancer resistance protein in adult acute lymphocytic leukemia and its clinical significance].
Jiang XJ; Wang JS; Fang Q
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Feb; 16(1):31-4. PubMed ID: 18315895
[TBL] [Abstract] [Full Text] [Related]
8. Expression of drug pathway proteins is independent of tumour type.
Zhang W; Shannon WD; Duncan J; Scheffer GL; Scheper RJ; McLeod HL
J Pathol; 2006 Jun; 209(2):213-9. PubMed ID: 16508919
[TBL] [Abstract] [Full Text] [Related]
9. Multidrug resistance transporters and modulation.
Tan B; Piwnica-Worms D; Ratner L
Curr Opin Oncol; 2000 Sep; 12(5):450-8. PubMed ID: 10975553
[TBL] [Abstract] [Full Text] [Related]
10. [Low-grade non-Hodgkin's lymphomas. Study of 73 cases].
Coma A; Jonte F; Zanabili Y; Soto I; Fanjul F; Carrera D; Rayón C; Luño E; Jalón S; Pinto V
Sangre (Barc); 1992 Aug; 37(4):249-54. PubMed ID: 1514137
[TBL] [Abstract] [Full Text] [Related]
